Renin inhibition with aliskiren

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 4, 2008, Pages 426-430

  Wuerzner, Grégoire ^a,b,c   Azizi, Michel ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c INSERM   (France)

Author keywords

Hypertension; Inhibitor; Pharmacology; Renin

Indexed keywords

ALISKIREN; AMLODIPINE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BRADYKININ; CALCIUM CHANNEL BLOCKING AGENT; CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; IRBESARTAN; LISINOPRIL; LOSARTAN; NITRIC OXIDE; POTASSIUM; PRORENIN; PRORENIN RECEPTOR; RAMIPRIL; RECEPTOR; RENIN; RENIN INHIBITOR; UNCLASSIFIED DRUG; VALSARTAN;

BLOOD PRESSURE REGULATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; DIARRHEA; DRUG BIOAVAILABILITY; DRUG DOSE COMPARISON; DRUG HALF LIFE; DRUG POTENCY; HUMAN; HYPERTENSION; HYPOKALEMIA; IC 50; MOLECULAR MODEL; MONOTHERAPY; NONHUMAN; POTASSIUM BLOOD LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIDE EFFECT; TREATMENT RESPONSE; X RAY CRYSTALLOGRAPHY;

AMIDES; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FUMARATES; HUMANS; HYPERTENSION;

EID: 40149093900     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.04890.x     Document Type: Conference Paper

References (65)